Comprehensive Breast Cancer Diagnostics Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034

"What Is the Future Outlook for the Breast Cancer Diagnostics Market's Size and Growth Rate?
In recent times, there has been significant expansion in the market size of breast cancer diagnostics. The market which had a value of $4.68 billion in 2024 is projected to marvelously escalate to $5.04 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The historic growth can be traced back to factors such as increased awareness and screening drives, technological innovation, genetic testing, and the implementation of a multidisciplinary strategy in mammography screening.

The market size for breast cancer diagnostics is projected to experience substantial expansion in the coming years. It is forecasted to reach a value of $6.91 billion by 2029, expanding at a compound annual growth rate (CAGR) of 8.2%. Factors contributing to the growth during the forecast period include the adoption of personalized medicine, liquid biopsies, 3d mammography (tomosynthesis), artificial intelligence, and machine learning, along with the increasing practice of telemedicine and remote consultations. The upcoming trends during this time frame involve advancements in imaging technologies, further development in personalized medicine, liquid biopsies, artificial intelligence, and machine learning.

What Is Stimulating Growth in the Breast Cancer Diagnostics Market?
The rise in breast cancer cases will necessitate more diagnostic equipment, resulting in increased demand in the breast cancer diagnostics market. Breast cancer, which impacts 2.1 million women annually, is the most prevalent type of cancer and leads to the highest number of cancer-related fatalities among women. The objective of early detection is to increase the ratio of breast cancers identified at a preliminary stage, allowing for more effective treatments and a reduction in the mortality risk related to breast cancer. For example, the American Cancer Society, a US-based organization dedicated to cancer eradication, reported in January 2022 that they anticipate around 287,850 new cases of invasive breast cancer and 51,400 incidences of DCIS in the United States in 2022, with approximately 43,250 expected deaths due to breast cancer. Consequently, the growing prevalence of breast cancer is projected to fuel the expansion of the breast cancer diagnostics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

Which Key Market Leaders Are Driving Breast Cancer Diagnostics Industry Growth?
Major companies operating in the breast cancer diagnostics market include Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.

What Are the Emerging Trends in the Breast Cancer Diagnostics Industry?
The evolution of technology is a significant trend in the breast cancer diagnostics market. Various innovative techniques have emerged that may play a role in diagnosing and treating breast cancer. One such technique includes 3D mammography, or breast tomosynthesis, which obtains images of the breast from multiple viewpoints and converts them into a 3-D representation. Niramai, an Health-Tech corporation from India, introduced an inventive tool named Thermalytix in September 2022. This product is an automated solution for diagnosing and screening breast cancer, integrating thermal imaging with artificial intelligence.

What Are the Main Segments in the Breast Cancer Diagnostics Market?
The breast cancer diagnostics market covered in this report is segmented -

1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types
2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types
4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies
5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

Subsegments:
1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis
2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy
3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing
4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests
5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Which Geographic Area Leads the Breast Cancer Diagnostics Market?
North America was the largest region in the breast cancer diagnostics market in 2023. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Breast Cancer Diagnostics Global Market Report?

- Market Size Analysis: Analyze the Breast Cancer Diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Breast Cancer Diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Breast Cancer Diagnostics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Breast Cancer Diagnostics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3284

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.